1/3 of a year

  • if vaccine-escape variant emerges, Companys expect to develop and produce tailor-made vaccine against that variant in about 100 days

Ok, so that is a rough timescale in case this blows up. Also remember that BioNTech expects dat from lab tests on new South African COVID variant in two weeks and that may require a vaccine adjustment.

This is likely to be a slow burn and risk markets are not quite sure what to do. Buy the dip or ditch risk?

With the weekend ahead watch for risk aversion heading into the weekend with significant risk of gapping over the weekend.